CSPC Pharmaceutical Group Limited Share Price
Stocks
1093
HK1093012172
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.890 HKD | -0.58% |
|
-4.83% | -18.27% |
| 06-18 | CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA | MT |
| 06-18 | CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China | MT |
| Market Cap | 78.77B 10.05B 8.76B 8.12B 7.6B 14.25B 948B 14.34B 96.29B 37.32B 467B 37.73B 36.92B 1,621B | P/E 2026 * |
9.77x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 67.72B 8.64B 7.53B 6.98B 6.53B 12.25B 815B 12.33B 82.79B 32.08B 401B 32.44B 31.74B 1,394B | EV / Sales 2026 * |
1.91x | EV / Sales 2027 * | 1.86x |
| Free-Float |
67.53% | Yield 2026 * |
5.21% | Yield 2027 * | 5.31% |
| 1 day | -0.58% | ||
| 1 week | -4.83% | ||
| Current month | -8.13% | ||
| 1 month | -7.52% | ||
| 3 months | -23.61% | ||
| 6 months | -15.98% | ||
| Current year | -18.27% |
| 1 week | 6.75 |  | 7.57 |
| 1 month | 6.64 | | 7.88 |
| Current year | 6.64 | | 10.96 |
| 1 year | 6.64 | | 11.63 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.9 |
| 10 years | 3.37 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 18/12/2025 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 18/12/2025 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 30/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 25/08/2011 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 19/01/2012 |
Bo Wang
BRD | Director/Board Member | 66 | 20/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-28 | Other | Chairman | 9,402,000 | 0.0816% | ||
| 05-27 | Other | Chairman | 40,000,000 | 0.3471% | ||
| 12-22 | Other | Chairman | 6,706,000 | 0.0582% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.58% | -4.83% | -9.46% | -2.13% | 10.05B | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 316B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 272B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 268B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 199B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.33% | -3.16% | +16.25% | +35.62% | 331.24B | |
| Weighted average by Cap. | -0.78% | -3.68% | +27.69% | +63.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35.53B 4.53B 3.95B 3.66B 3.43B 6.43B 428B 6.47B 43.43B 16.83B 211B 17.02B 16.65B 731B | 35.14B 4.48B 3.91B 3.62B 3.39B 6.36B 423B 6.39B 42.95B 16.65B 208B 16.83B 16.47B 723B |
| Net income | 7.73B 986M 860M 796M 745M 1.4B 93.05B 1.41B 9.45B 3.66B 45.8B 3.7B 3.62B 159B | 6.89B 880M 767M 710M 665M 1.25B 83.01B 1.25B 8.43B 3.27B 40.86B 3.3B 3.23B 142B |
| Net Debt | -11.05B -1.41B -1.23B -1.14B -1.07B -2B -133B -2.01B -13.51B -5.24B -65.49B -5.29B -5.18B -227B | -13.34B -1.7B -1.48B -1.37B -1.29B -2.41B -161B -2.43B -16.3B -6.32B -79.04B -6.39B -6.25B -274B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 6.890 $ | -0.58% | 75,823,040 |
| 17/06/26 | 6.930 $ | -2.12% | 48,049,460 |
| 16/06/26 | 7.080 $ | -3.67% | 56,955,510 |
| 15/06/26 | 7.350 $ | +1.52% | 76,798,290 |
| 12/06/26 | 7.240 $ | +0.42% | 91,647,920 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Select your edition
All financial news and data tailored to specific country editions
